| [1] |
Ebata T, Yokoyama Y, Igami T, et al. Review of hepatopancreatoduodenectomy for biliary cancer: an extended radical approach of Japanese origin[J]. J Hepatobiliary Pancreat Sci, 2014, 21(8):550-555.
|
| [2] |
Nagino M. Fifty-year history of biliary surgery[J]. Ann Gastroenterol Surg, 2019, 3(6):598-605.
|
| [3] |
Capobianco I, Rolinger J, Nadalin S. Resection for Klatskin tumors: technical complexities and results[J]. Transl Gastroenterol Hepatol, 2018, 3: 69.
|
| [4] |
Feo CF, Ginesu GC, Barmina M, et al. Curative resection for hilar cholangiocarcinoma: single-center experience with long-term follow-up[J]. Am Surg, 2018, 84(1):9-10.
|
| [5] |
Kaneoka Y, Yamaguchi A, Isogai M, et al. Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy[J]. World J Surg, 2010, 34(11):2662-2670.
|
| [6] |
Fernandes EDES, Mello FT, Ribeiro-Filho J, et al. The largest western experience with hepatopancreatoduodenectomy: lessons learned with 35 cases[J]. Braz Arch Dig Surg, 2016, 29(1):17-20.
|
| [7] |
Welch JC, Gleeson EM, Karachristos A, et al. Hepatopancreatoduodenectomy in North America: are the outcomes acceptable?[J]. HPB, 2020, 22(3):360-367.
|
| [8] |
D'Souza MA, Valdimarsson VT, Campagnaro T, et al. Hepatopancreatoduodenectomy-a controversial treatment for bile duct and gallbladder cancer from a European perspective[J]. HPB, 2020, 22(9):1339-1348.
|
| [9] |
Liu F, Hu HJ, Ma WJ, et al. Is radical resection of hilar cholangiocarcinoma plus partial resection of pancreatic head justified for advanced hilar cholangiocarcinoma?[J]. ANZ J Surg, 2020, 90(9):1666-1670.
|
| [10] |
Zhou Y, Zhang Z, Wu L, et al. A systematic review of safety and efficacy of hepatopancreatoduodenectomy for biliary and gallbladder cancers[J]. HPB, 2016, 18(1):1-6.
|
| [11] |
Iacono C, de Bellis M, Guglielmi A. ASO author reflections: hepatopancreatoduodenectomy: why, when, and how?[J]. Ann Surg Oncol, 2020, 27(9):3358-3359.
|
| [12] |
Dai WC, Chok KS, Cheung TT, et al. Hepatopancreatoduodenectomy for advanced hepatobiliary malignancies: a single-center experience[J]. Hepatobiliary Pancreat Dis Int, 2017, 16(4):382-386.
|
| [13] |
Utsumi M, Sadamori H, Shinoura S, et al. Risk factors of morbidity and predictors of long-term survival after hepatopancreatoduodenectomy for biliary cancer[J]. Hepatogastroenterology, 2014, 61(136):2167-2172.
|
| [14] |
Fukami Y, Kaneoka Y, Maeda A, et al. Major hepatopancreatoduodenectomy with simultaneous resection of the hepatic artery for advanced biliary cancer[J]. Langenbecks Arch Surg, 2016, 401(4):471-478.
|
| [15] |
Ishii T, Seo S, Ito T, et al. Liver transection-first approach in hepatopancreatoduodenectomy for hilar cholangiocarcinoma: a safe and secure technique for the early assessment of curable resection and vascular reconstruction[J]. Ann Surg Oncol, 2021, 28(6):2988-2989.
|
| [16] |
Hemming AW. Hepatopancreatoduodenectomy in North America: acceptable outcomes?[J]. HPB, 2020, 22(3):358-359.
|
| [17] |
Aoki T, Sakamoto Y, Kohno Y, et al. Hepatopancreaticoduodenectomy for biliary cancer: strategies for near-zero operative mortality and acceptable long-term outcome[J]. Ann Surg, 2018, 267(2):332-337.
|
| [18] |
Otsubo T, Kobayashi S, Sano K, et al. Safety-related outcomes of the Japanese Society of Hepato-Biliary-Pancreatic Surgery board certification system for expert surgeons[J]. J Hepatobiliary Pancreat Sci, 2017, 24(5):252-261.
|
| [19] |
Ebata T, Yokoyama Y, Igami T, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients[J]. Ann Surg, 2012, 256(2):297-305.
|
| [20] |
Nagaraj K, Goto Y, Kojima S, et al. Central hepatopancreatoduodenectomy-oncological effectiveness and parenchymal sparing option for diffusely spreading bile duct cancer: report of two cases[J]. BMC Surg, 2021, 21(1):23.
|
| [21] |
Shimizu A, Motoyama H, Kubota K, et al. Safety and oncological benefit of hepatopancreatoduodenectomy for advanced extrahepatic cholangiocarcinoma with horizontal tumor spread: shinshu university experience[J]. Ann Surg Oncol, 2021, 28(4):2012-2025.
|
| [22] |
Mizuno T, Ebata T, Nagino M. Advanced hilar cholangiocarcinoma: an aggressive surgical approach for the treatment of advanced hilar cholangiocarcinoma: Perioperative management, extended procedures, and multidisciplinary approaches[J]. Surg Oncol, 2020, 33:201-206.
|
| [23] |
Nigri GR, Rosman AS, Petrucciani N, et al. Metaanalysis of trials comparing minimally invasive and open distal pancreatectomies[J]. Surg Endosc, 2011, 25(5):1642-1651.
|
| [24] |
Zhou Y, Yang C, Wang S, et al. Does external pancreatic duct stent decrease pancreatic fistula rate after pancreatic resection?: a meta-analysis[J]. Pancreatology, 2011, 11(3):362-370.
|
| [25] |
Miwa S, Kobayashi A, Akahane Y, et al. Is major hepatectomy with pancreatoduodenectomy justified for advanced biliary malignancy?[J]. J Hepatobiliary Pancreat Surg, 2007, 14(2):136-141.
|
| [26] |
Yamamoto Y, Sugiura T, Okamura Y, et al. Is combined pancreatoduodenectomy for advanced gallbladder cancer justified?[J]. Surgery, 2016, 159(3):810-820.
|
| [27] |
Sakamoto Y, Nara S, Kishi Y, et al. Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer?[J]. Surgery, 2013, 153(6):794-800.
|
| [28] |
夏果毅, 刘苏来, 孙增鹏, 等. 肝胰十二指肠切除在6例T4期胆囊癌患者治疗中的应用[J]. 中华普通外科杂志, 2022, 37(6):461-463.
|
| [29] |
Wu X, Li M, Wu W, et al. Hepatopancreatoduodenectomy for advanced biliary malignancies[J]. Chin Med J, 2022, 135(23):2851-2858.
|
| [30] |
Toyoda Y, Ebata T, Mizuno T, et al. Cholangiographic tumor classification for simple patient selection prior to hepatopancreatoduodenectomy for cholangiocarcinoma[J]. Ann Surg Oncol, 2019, 26(9):2971-2979.
|
| [31] |
王健东, 全志伟. 重视胆道恶性肿瘤化疗联合靶向免疫的综合治疗[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(2):125-130.
|